Abstracts tagged "rheumatoid arthritis (RA) and remission"

Abstract Number: 1173 • 2019 ACR/ARP Annual Meeting
Magnetic Resonance Imaging in Patients in Clinical Remission: Tenosynovitis and Osteitis Are Independent Predictors of Radiographic and MRI Damage Progression
Signe Møller-Bisgaard¹, Kim Hørslev-Petersen ², Bo Ejbjerg ³, Merete Lund Hetland ⁴, Lykke Midtbøll Ørnbjerg ¹, Daniel Glinatsi ¹, Jakob Møller ⁵, Mikael Boesen ⁶, Kristian Stengaard-Pedersen ⁷, Ole Rintek Madsen ⁸, Bente Jensen ⁹, Jan Alexander Villadsen ¹⁰, Ellen-Margrethe Hauge ⁷, Philip Bennett ¹¹, Oliver Hendricks ¹², Karsten Asmussen ⁹, Marcin Kowalski ¹³, Hanne Lindegaard ¹⁴, Henning Bliddal ¹⁵, Niels Steen Krogh ¹⁶, Torkell Ellingsen ¹⁷, Agnete Nielsen ¹⁸, Lone Balding ⁵, Anne Grethe Jurik ¹⁹, Henrik Thomsen ⁵ and Mikkel Østergaard ²⁰, ¹Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Denmark, Copenhagen, Denmark, ²Department of Rheumatology, King Christian X’s Hospital for Rheumatic Diseases Graasten, Denmark, Graasten, Denmark, ³Department of Rheumatology, Zealand University Hospital, Køge, Denmark, Køge, Denmark, ⁴DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, ⁵Department of Radiology, Herlev and Gentofte University Hospital, Herlev, Denmark, Copenhagen, Denmark, ⁶Department of Radiology, Bispebjerg and Frederiksberg University Hospital, Frederiksberg, Denmark, Copenhagen, Denmark, ⁷Department of Rheumatology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark, Aarhus, Denmark, ⁸Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark, ⁹Department of Rheumatology, Bispebjerg and Frederiksberg University Hospital, Frederiksberg, Denmark, Copenhagen, Denmark, ¹⁰Department of Rheumatology, Silkeborg Hospital, Silkeborg, Denmark, Silkeborg, Denmark, ¹¹Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte, Hellerup, Denmark, Copenhagen, Denmark, ¹²Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark, Sønderborg, Denmark, ¹³Department of Rheumatology, Hjørring Hospital, Hjørring, Denmark, Hjørring, Denmark, ¹⁴Department of Rheumatology, Odense University Hospital, Odense, Denmark, Odense, Denmark, ¹⁵The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark, Copenhagen, Denmark, ¹⁶Zitelab / DANBIO, Copenhagen, Denmark, ¹⁷Department of Rheumatology, Odense University Hospital, Denmark, Odense, Syddanmark, Denmark, ¹⁸Department of Radiology, Silkeborg Hospital, Silkeborg, Denmark, Silkeborg, Denmark, ¹⁹Department of Radiology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Denmark, ²⁰Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark
Background/Purpose: Progression of structural joint damage develops in 20-30 % of patients with rheumatoid arthritis (RA) in clinical remission1. Known predictors of structural damage progression…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].